Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa, Does Not Interfere with Antithrombin or TFPI Activity In Vitro

Emicizumab is a humanized bispecific antibody that binds simultaneously to factor (F) IXa and FX replacing the cofactor function of FVIIIa. Because emicizumab recognizes FIX/FIXa and FX/FXa, a question may arise whether emicizumab competes with antithrombin (AT) and/or tissue factor pathway inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Noguchi-Sasaki, Mariko, Soeda, Tetsuhiro, Ueyama, Atsunori, Muto, Atsushi, Hirata, Michinori, Kitamura, Hidetomo, Fujimoto-Ouchi, Kaori, Kawabe, Yoshiki, Nogami, Keiji, Shima, Midori, Kitazawa, Takehisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524866/
https://www.ncbi.nlm.nih.gov/pubmed/31249933
http://dx.doi.org/10.1055/s-0038-1636538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524866/
https://www.ncbi.nlm.nih.gov/pubmed/31249933
http://dx.doi.org/10.1055/s-0038-1636538

Ejemplares similares